Change in Mammographic Density as a Marker of Tamoxifen Effect in Premenopausal Breast Cancer June 23, 2016
MammaPrint is a Useful Predictor of Chemotherapy Benefit for Estrogen Receptor-Positive (ER+) Breast Cancer Patients June 13, 2016